In January 2018, we appointed two new additions to our Board of Directors, Laura Wade-Gery and Kristine Peterson, who will join us as Non-Executive Directors. Laura has more than 20 years’ of transferable executive experience across business and commerce. She most recently served as Executive Director at Marks and Spencer Group plc (M&S), transforming its online business.
Kristine brings 30 years’ experience from the global pharmaceutical and biotech industry. In her previous role as Chief Executive Officer (CEO) of Valeritas, Inc. she led them from early stage R&D to commercialisation of the company’s Type 2 diabetes drug-device.
The wealth of experience brought by both Laura and Kristine from business, commerce and pharmaceuticals will be invaluable as Immunocore scales up its commercial infrastructure and prepares for the advance of its lead programme, IMCgp100.